Mounjaro dose for weight loss: how the schedule is decided

Why there isn't one 'best' dose, and what actually drives the decision

The question our prescribers hear most weeks is some version of: "What's the best dose of Mounjaro for weight loss?" The honest answer is that it depends entirely on the individual. Mounjaro works by activating both GIP and GLP-1 receptors, reducing appetite and slowing how quickly your stomach empties. Those effects tend to strengthen at higher doses, which is why the 15 mg maintenance dose produced the largest average weight losses in SURMOUNT-1, published in the New England Journal of Medicine. But tolerability is the gating factor. Someone who experiences significant nausea at 5 mg may not safely reach 15 mg quickly, and rushing can make side effects worse without improving results. So the "best" dose is whichever you can sustain comfortably and that your prescriber judges appropriate for your health picture. That is rarely determined at the start; it reveals itself over months of careful titration. If you want to understand how many mg of Mounjaro tends to be appropriate for weight loss at different stages, that guide is worth reading alongside your prescriber's advice. If you want to understand how the earliest part of the schedule tends to feel, the 2.5 mg starter period is worth reading about before you begin.

How each step in the schedule is supposed to work

The titration ladder is not arbitrary. Starting at 2.5 mg gives your gastrointestinal system time to adapt to Mounjaro's mechanism before the appetite-suppressing effect is turned up. Nausea, the most common side effect, is almost always at its most noticeable when a dose changes, then settles over the following week or two. This is why the four-week minimum at each step matters, moving up too quickly risks stacking a new wave of side effects on top of one that hasn't resolved. By the time most people reach 5 mg, the early discomfort has usually eased considerably. From there, the prescriber reviews progress at each stage: meaningful weight loss, tolerability, and whether there's a clinical reason to pause. Some people find 5 mg or 7.5 mg is their long-term sweet spot; others progress steadily to 15 mg. The full Mounjaro dosage guide on our site covers each rung of the schedule in more detail. What the clinical data show clearly is that the proportion of people losing 15% or more of their body weight rises at each dose step, which is why prescribers try to reach the highest well-tolerated dose rather than staying low indefinitely.

What the trial evidence says about higher doses

SURMOUNT-1 randomised thousands of adults across the three higher dose groups (5 mg, 10 mg and 15 mg) alongside placebo over 72 weeks. Average weight reduction at 10 mg was around 19–20%; at 15 mg, around 20–21%. Those are averages from a trial setting with close monitoring and lifestyle support; real-world results vary. The NICE appraisal of tirzepatide, TA1026, considered this evidence base in recommending it for adults with a BMI of 35 or above and at least one weight-related condition on the NHS. Privately, the eligibility threshold is lower (BMI 30 or above, or 27 or above with a qualifying condition) and your prescriber assesses the whole picture before approving any dose change. If you're weighing up what treatment looks like from a cost perspective, our weight-loss treatments page sets out what's included transparently. One practical note: if your progress at the highest tolerated dose is less than 5% after six months, guidelines suggest that continuing may be reviewed. That conversation belongs with your prescriber.

The side-effect picture as doses increase

Understanding the side-effect profile helps you make sense of why slower titration protects results rather than slowing them. Gastrointestinal effects (nausea, loose stools, indigestion, burping) are the most common and are most intense at higher doses or after a step-up. They typically settle within one to two weeks. Less common but worth knowing: fatigue and headache can appear after a dose change. Rare but serious signs to act on promptly include severe, persistent abdominal pain that spreads to the back, the MHRA has flagged acute pancreatitis as an infrequent but potentially serious risk with GLP-1 medicines, and that symptom pattern warrants urgent medical attention. The NHS tirzepatide medicines page lists the full side-effect profile in plain language. Injection-site reactions can occur; rotating between the abdomen, thigh and upper arm on a cycle helps. There is also a practical interaction to know: women taking oral contraceptives should add a non-oral method for the first four weeks of treatment and for four weeks after each dose increase, because the pill's absorption may be reduced. Storage is straightforward (the pen lives in the fridge) but always check the Patient Information Leaflet for the exact room-temperature window rather than relying on a general figure. For a closer look at how the 5 mg step tends to feel in practice, this page on 5 mg weight loss goes into more depth. Questions about a specific higher step? The 10 mg page covers what to expect when the dose reaches that level. It is also worth knowing that some pens contain more than a single injection, and our page explaining the Mounjaro bonus dose sets out exactly what that means and how to make the most of it.